Pathogenesis of Alcoholic Fatty Liver a Narrative Review
- PMID: 37629519
- PMCID: PMC10455719
- DOI: 10.3390/life13081662
Pathogenesis of Alcoholic Fatty Liver a Narrative Review
Abstract
Alcohol effect hepatic lipid metabolism through various mechanisms, leading synergistically to an accumulation of fatty acids (FA) and triglycerides. Obesity, as well as dietary fat (saturated fatty acids (FA) versus poly-unsaturated fatty acids (PUFA)) may modulate the hepatic fat. Alcohol inhibits adenosine monophosphate activated kinase (AMPK). AMPK activates peroxisome proliferator activated receptor a (PPARα) and leads to a decreased activation of sterol regulatory element binding protein 1c (SRABP1c). The inhibition of AMPK, and thus of PPARα, results in an inhibition of FA oxidation. This ß-oxidation is further reduced due to mitochondrial damage induced through cytochrome P4502E1 (CYP2E1)-driven oxidative stress. Furthermore, the synthesis of FAs is stimulated through an activation of SHREP1. In addition, alcohol consumption leads to a reduced production of adiponectin in adipocytes due to oxidative stress and to an increased mobilization of FAs from adipose tissue and from the gut as chylomicrons. On the other side, the secretion of FAs via very-low-density lipoproteins (VLDL) from the liver is inhibited by alcohol. Alcohol also affects signal pathways such as early growth response 1 (Egr-1) associated with the expression of tumour necrosis factor α (TNF α), and the mammalian target of rapamycin (mTOR) a key regulator of autophagy. Both have influence the pathogenesis of alcoholic fatty liver. Alcohol-induced gut dysbiosis contributes to the severity of ALD by increasing the metabolism of ethanol in the gut and promoting intestinal dysfunction. Moreover, pathogen-associated molecular patterns (PAMPS) via specific Toll-like receptor (TLR) bacterial overgrowth leads to the translocation of bacteria. Endotoxins and toxic ethanol metabolites enter the enterohepatic circulation, reaching the liver and inducing the activation of the nuclear factor kappa-B (NFκB) pathway. Pro-inflammatory cytokines released in the process contribute to inflammation and fibrosis. In addition, cellular apoptosis is inhibited in favour of necrosis.
Keywords: adenosine monophosphate activated kinase; alcoholic fatty liver; cytochrome P450 2E1; oxidative stress; peroxisome proliferator activated receptor α; sterol regulatory element binding protein 1c.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.Crit Rev Food Sci Nutr. 2019;59(sup1):S116-S129. doi: 10.1080/10408398.2018.1544542. Epub 2018 Dec 22. Crit Rev Food Sci Nutr. 2019. PMID: 30580553 Review.
-
Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.Alcohol. 2004 Aug;34(1):3-8. doi: 10.1016/j.alcohol.2004.06.008. Alcohol. 2004. PMID: 15670659
-
Aqueous Extract of Pepino (Solanum muriactum Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease.Nutrients. 2018 Jul 20;10(7):931. doi: 10.3390/nu10070931. Nutrients. 2018. PMID: 30037014 Free PMC article.
-
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.Alcohol. 2004 Aug;34(1):9-19. doi: 10.1016/j.alcohol.2004.07.008. Alcohol. 2004. PMID: 15670660 Review.
-
S-Allylmercaptocysteine improves alcoholic liver disease partly through a direct modulation of insulin receptor signaling.Acta Pharm Sin B. 2021 Mar;11(3):668-679. doi: 10.1016/j.apsb.2020.11.006. Epub 2020 Nov 13. Acta Pharm Sin B. 2021. PMID: 33777674 Free PMC article.
Cited by
-
Food plants as adjuvant medicines: a review of protective effects and clinical potential in alcoholic liver disease.Front Pharmacol. 2025 May 22;16:1586238. doi: 10.3389/fphar.2025.1586238. eCollection 2025. Front Pharmacol. 2025. PMID: 40474973 Free PMC article. Review.
-
Gut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease.Hepatology. 2024 Dec 1;80(6):1342-1371. doi: 10.1097/HEP.0000000000000924. Epub 2024 May 1. Hepatology. 2024. PMID: 38691396 Review.
-
Probiotics-role in alleviating the impact of alcohol liver disease and alcohol deaddiction: a systematic review.Front Nutr. 2024 Aug 30;11:1372755. doi: 10.3389/fnut.2024.1372755. eCollection 2024. Front Nutr. 2024. PMID: 39290562 Free PMC article.
-
Alcohol in Daily Products: Health Risks, Cultural Considerations, and Economic Impacts.Risk Manag Healthc Policy. 2025 Jan 18;18:217-237. doi: 10.2147/RMHP.S495493. eCollection 2025. Risk Manag Healthc Policy. 2025. PMID: 39845405 Free PMC article. Review.
-
Alcohol Exposure May Increase Prenatal Choline Needs Through Redirection of Choline into Lipid Synthesis Rather than Methyl Donation.Metabolites. 2025 Apr 24;15(5):289. doi: 10.3390/metabo15050289. Metabolites. 2025. PMID: 40422867 Free PMC article.
References
-
- Seitz H.K., Mueller S. Alcoholic Liver Disease. In: Dancygier H., editor. Clinical Hepatology. Principle and Practice of Hepatobiliary Diseases. Volume 2. Springer; Berlin/Heidelberg, Germany: 2010. pp. 1111–1151.
-
- Hall P.D. Pathological Spectrum of Alcoholic Liver Disease. In: Hall P., editor. Alcoholic Liver Disease. Pathology and Pathogenesis. 2nd ed. Edward Arnold; London, UK: 1995. pp. 41–70.
-
- Simonis B., Reimann F., Waldherr R., Seitz H.K. Sonographic course of alcoholic fatty liver by inter-observer and digital evaluation of liver echogenicity. Zeitschr. Gastroenterol. 2007;45:689–696. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous